Spifen MR 50mg/4mg Tablet
By Spifen MR
Rx
10 Tablet in a Strip

Composition
Ketoprofen(50mg) + Thiocolchicoside(4mg)

Manufacturer - Fawn Incorporation
Plot No 404, Industrial Area, Phase 1, Panchkula

Expires on or after
July, 2025

liver
Limited information is accessible regarding the utilization of Spifen MR 50mg/4mg Tablet in individuals with liver disease. It is advisable to seek guidance from your doctor before using this medication.

kidney
Spifen MR 50mg/4mg Tablet needs caution in kidney disease patients. Dose adjustment may be necessary. Consult your doctor and monitor kidney function regularly during use. Avoid if severe kidney disease.

alcohol
It is not safe to drink alcohol while taking Spifen MR 50mg/4mg Tablet.

driving
Caution Spifen MR 50mg/4mg Tablet may cause side effects impacting driving ability.

pregnancy
Spifen MR 50mg/4mg Tablet may be unsafe during pregnancy. Limited human studies show potential risks and animal studies indicate harm to the developing baby. Your doctor will assess benefits and risks before prescribing. Consult your doctor regarding its usage in pregnancy.

breastfeeding
It is better to consult your doctor before using Spifen MR 50mg/4mg Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹199.9
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025